LOM
ATRS

Loeb Offshore Management’s Antares Pharma, Inc. ATRS Stock Holding History

Loeb Offshore Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-30,544
Closed -$124K – 251
2013
Q3 		$124K Buy
+30,544
New +$133K 0.04% 207

Other funds holding ATRS

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
WHI
William Harris Investors Chicago, Illinois $347M AUM 3.53% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Loeb Offshore Management's ATRS Position: Q4 2013 in Review

Loeb Offshore Management sold out of Antares Pharma, Inc. (ATRS) in Q4 2013, closing a stake of 30,544 shares — an estimated $124K sold.

Loeb Offshore Management first reported a position in ATRS in Q3 2013 and held it in 1 quarter. The position peaked at $124K in Q3 2013. 89 funds tracked by Wall St. Rank hold ATRS as of Q4 2013.

  • Loeb Offshore Management reported no remaining Antares Pharma, Inc. position as of Q4 2013 after selling out during the quarter.
  • Loeb Offshore Management sold 30,544 Antares Pharma, Inc. shares in Q4 2013, an estimated $124K.
  • Loeb Offshore Management first reported a position in Antares Pharma, Inc. in Q3 2013 and held it in 1 quarter.
  • Loeb Offshore Management's Antares Pharma, Inc. position peaked at $124K in Q3 2013.
  • 89 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2013.

Based on Loeb Offshore Management's 13F filing for Q4 2013, filed 14 Feb 2014.